- US11987644utility2024Method of Manufacturing Bispecific Antibodies, Bispecific Antibodies and Therapeutic Use of Such Antibodies0 cites
- US11981731utility2024Targeting Cytotoxic Cells with Chimeric Receptors for Adoptive Immunotherapy0 cites
- US11975026utility2024CD19 and CD22 Chimeric Antigen Receptors and Uses Thereof0 cites
- US11970497utility2024Tricyclic AKR1C3 Dependent KARS Inhibitors0 cites
- US11963999utility2024Methods of Treating HIV-HAART Induced Partial Lipodystrophy with FGF21 Protein Variant FC Fusion Proteins0 cites
- US11958805utility2024Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof0 cites
- US11958846utility2024Urea Compounds and Compositions as SMARCA2/BRM Atpase Inhibitors0 cites
- US11951101utility2024Methods of Using Factor B Inhibitors0 cites
- US11952386utility2024N-azaspirocycloalkane Substituted N-heteroaryl Compounds and Compositions for Inhibiting the Activity of SHP20 cites
- US11952428utility2024BCMA Chimeric Antigen Receptors and Uses Thereof0 cites
- US11944602utility2024Treatment of Autoimmune Disease in a Patient Receiving Additionally a Beta-blocker0 cites
- US11944664utility2024Fibroblast Growth Factor-21-fc Fusion Proteins0 cites
- US11945859utility2024Protein Solution Formulation Containing High Concentration of an Anti-vegf Antibody0 cites
- US11939389utility2024BCMA Chimeric Antigen Receptors and Uses Thereof0 cites
- US11939397utility2024ENTPD2 Antibodies, Combination Therapies, and Methods of Using the Antibodies and Combination Therapies0 cites
- US11930837utility2024Antibody-cytokine Engrafted Proteins and Methods of Use for Immune Related Disorders0 cites
- US11931363utility2024Triazolopyrimidine Compounds and Uses Thereof0 cites
- US11931430utility2024Labeled Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Agents for the Treatment of Prostate Cancer0 cites
- US11932681utility2024Hepatitis B Antibodies0 cites